SALL4 Affects the Side Population 25. Yang J, Chai L, Fowles TC, Alipio Z, Xu D, et al. (2008) Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc Natl Acad Sci U S A 105(50): 19756–61. 26. Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, et al. (2006) Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 8(10): 1114–23. 27. Ma Y, Cui W, Yang J, Qu J, Di C, et al. (2006) SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood 108(8): 2726–35. 28. Yang J, Chai L, Gao C, Fowles TC, Alipio Z, et al. (2008) SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood 112(3): 805–13. 29. Yang J, Chai L, Liu F, Fink LM, Lin P, et al. (2007) Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proc Natl Acad Sci U S A 104(25): 10494–9. 30. Lu J, Jeong H, Kong N, Yang Y, Carroll J, et al. (2009) Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex. PLoS ONE 4(5): e5577. 31. Yang J, Gao C, Chai L, Ma Y (2010) A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS One 5(5): e10766. 32. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, et al. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103(4): 620–5. 33. Cui W, Kong NR, Ma Y, Amin HM, Lai R, et al. (2006) Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia. Mod Pathol 19(12): 1585–92. 34. Bard JD, Gelebart P, Amin HM, Young LC, Ma Y, et al. (2009) Signal transducer and activator of transcription 3 is a transcriptional factor regulating the gene expression of SALL4. Faseb J 23(5): 1405–14. 35. Cao D, Humphrey PA, Allan RW (2009) SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 115(12): 2640–51. 36. Verhaak RG, Wouters BJ, Erpelinck CA, Abbas S, Beverloo HB, et al. (2009) Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica 94(1): 131–4. 37. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, et al. (2009) PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4(3): 226–35. 38. Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, et al. (2007) Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 104(41): 16158–63. PLoS ONE | www.plosone.org 12 April 2011 | Volume 6 | Issue 4 | e18372